clinical trial

esperion

More Positive Test Results For Plymouth Firm’s Cholesterol Drug

Esperion Therapeutics Inc. Tuesday announced positive results from a Phase 2a study of its drug candidate ETC-1002 when added to statin therapy in patients with high levels of low density lipoprotein cholesterol, the so-called bad cholesterol, in their blood.

WWJ Newsradio 950–09/03/2013

A scanning electron microscope picture of a cancer cell. Uncredited photo from Wikimedia Commons

Breast Cancer Clinical Trial Targets Cancer Stem Cells

A major reason that breast cancer returns after treatment and spreads to other parts of the body is that current chemotherapy and radiation treatments do not kill the cancer stem cells. That premise provides the basis for a clinical trial open at the University of Michigan Comprehensive Cancer Center and two other sites testing a drug that has been found in laboratory studies to attack cancer stem cells.

WWJ Newsradio 950–06/26/2013

A scanning electron microscope picture of a cancer cell. Uncredited photo from Wikimedia Commons

Clinical Trial Tests Targeting Prostate Cancer Treatment

A new clinical trial is testing whether targeting treatments to a genetic anomaly can lead to better treatments for prostate cancer. The trial, led by investigators at the University of Michigan Comprehensive Cancer Center, is being conducted at 11 sites throughout the country.

WWJ Newsradio 950–05/23/2013

aastrom

Aastrom Enrolls First Patients In Phase 2b Clinical Trial of Ixmyelocel-T

Aastrom Biosciences Inc. (Nasdaq:ASTM), the developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that the first patients have been enrolled in the ixCELL-DCM clinical trial.

WWJ Newsradio 950–04/04/2013

Rockwell Medical

Rockwell Medical Announces Iron Delivery Drug SFP Meets Goals

Wixom-based Rockwell Medical Monday announced successful results from a clinical study of Soluble Ferric Pyrophosphate, its investigational iron-delivery drug now in Phase 3 clinical studies for the treatment of iron deficiency in hemodialysis patients.

WWJ Newsradio 950–02/04/2013

AlphaCore Reports Positive Phase 1 Results For New Heart Drug

AlphaCore Pharma announced Tuesday that results from the company’s Phase 1 clinical trial have met the primary endpoint by demonstrating the safety and tolerability of the drug ACP-501 (recombinant human LCAT).

WWJ Newsradio 950–10/09/2012

metabolic solutions

New Treatment Possible For Type 2 Diabetes

A study published online in the Journal of Biological Chemistry showed a new drug to treat diabetes being developed by Metabolic Solutions Development Co. LLC, MSDC-0602, improved insulin resistance and inflammation in obese mice.

WWJ Newsradio 950–05/29/2012

Stryker Corp. headquarters in Kalamazoo.

Stryker Announces Positive Clinical Results From Trevo

Thursday at the European Stroke Conference in Lisbon, Portugal, Stryker announced positive results of the clincal trial of Stryker’s Trevo 2, a tool for removing blood clots from the blood vessels of stroke patients.

WWJ Newsradio 950–05/24/2012

University of Michigan Hospital (University of Michigan photo)

ALS Patients Approved For More Stem Cells

Three patients with amyotrophic lateral sclerosis will be permitted to receive a second dose of stem cells delivered directly to the spinal cord, in a clinical trial being led by the University of Michigan’s Eva Feldman, M.D.

WWJ Newsradio 950–05/09/2012

istockphoto

UM Part Of New Study Of Stem Cell Injections in Lou Gehrig’s Disease

The first published results from an early-stage clinical trial show that spinal cord stem cells can be delivered safely into the spines of patients with the condition commonly known as Lou Gehrig’s disease, opening the door for further research on this innovative approach.

WWJ Newsradio 950–04/10/2012

more

Follow

Get every new post delivered to your Inbox.

Join 2,325 other followers